Skip to main content
. 2017 Jul 11;8(45):79712–79721. doi: 10.18632/oncotarget.19161

Table 2A. Comparison of training and validation patients without recurrence.

Non-Recurrence (N = 101) Training (N = 73) Validation (N = 28)
Age, years (median ± SD) 62.0 ± 10.6 68.5 ± 15.5
Follow-up, months (median ± SD) 56.8 ± 12.1 55.9 ± 12.2
Sex, number (%)
 Male 36 (49.3) 15 (53.6)
 Female 37 (50.7) 13 (46.4)
Stage, number (%)
 IA 41 (56.2) 9 (32.1)
 IB 30 (41.1) 18 (64.3)
 IIA 1 (1.4) 0 (0.0)
 IIB 1 (1.4) 0 (0.0)
 IIIA 0 (0.0) 1 (3.6)

SD, standard deviation.